Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


10.09.2018

2 Acta Ophthalmol
1 Am J Kidney Dis
3 Ann Intern Med
1 Atherosclerosis
2 BMJ
8 Diabet Med
5 Diabetes
2 Diabetes Care
7 Diabetes Obes Metab
2 Diabetologia
2 J Am Coll Cardiol
1 J Am Soc Nephrol
2 J Diabetes Complications
1 J Pediatr
1 Kidney Int
2 Lancet Diabetes Endocrinol
6 Pediatr Diabetes
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. SCHREUR V, van Asten F, Ng H, Weeda J, et al
    Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus.
    Acta Ophthalmol. 2018;96:459-464.
    PubMed     Text format     Abstract available

  2. MENG W, Shah KP, Pollack S, Toppila I, et al
    A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes.
    Acta Ophthalmol. 2018 Sep 4. doi: 10.1111/aos.13769.
    PubMed     Text format     Abstract available


    Am J Kidney Dis

  3. JEPSON C, Hsu JY, Fischer MJ, Kusek JW, et al
    Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Am J Kidney Dis. 2018 Aug 31. pii: S0272-6386(18)30823.
    PubMed     Text format     Abstract available


    Ann Intern Med

  4. HUMPHREY LL, Kansagara D, Qaseem A
    World Health Organization Guidelines on Medicines for Diabetes Treatment Intensification: Commentary From the American College of Physicians High Value Care Committee.
    Ann Intern Med. 2018 Sep 4. pii: 2698899. doi: 10.7326/M18-1148.
    PubMed     Text format    

  5. ROGLIC G, Norris SL
    Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the
    Ann Intern Med. 2018 Sep 4. pii: 2698900. doi: 10.7326/M18-1149.
    PubMed     Text format     Abstract available

  6. CENTOR RM, Montori VM
    Web Exclusive. Annals On Call - Glycemic Control in Type 2 Diabetes: How Low Should We Go?
    Ann Intern Med. 2018;169:OC1.
    PubMed     Text format    


    Atherosclerosis

  7. MUNOZ-HERNANDEZ L, Ortiz-Bautista RJ, Brito-Cordova G, Lozano-Arvizu F, et al
    Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes.
    Atherosclerosis. 2018;277:72-79.
    PubMed     Text format     Abstract available


    BMJ

  8. RAMOS R, Comas-Cufi M, Marti-Lluch R, Ballo E, et al
    Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    BMJ. 2018;362:k3359.
    PubMed     Text format     Abstract available

  9. XU G, Liu B, Sun Y, Du Y, et al
    Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.
    BMJ. 2018;362:k1497.
    PubMed     Text format     Abstract available


    Diabet Med

  10. DASHORA U, George S, Sampson M, Walden E, et al
    National guidelines have contributed to safer care for inpatients with diabetes.
    Diabet Med. 2018 Sep 5. doi: 10.1111/dme.13815.
    PubMed     Text format     Abstract available

  11. FREDRIX M, Byrne M, Dinneen S, McSharry J, et al
    'It's an important part, but I am not quite sure that it is working': educators' perspectives on the implementation of goal-setting within the 'DAFNE' diabetes structured education programme.
    Diabet Med. 2018 Sep 3. doi: 10.1111/dme.13813.
    PubMed     Text format     Abstract available

  12. MCMORROW L, O' Hara MC, Hynes L, Cunningham A, et al
    The preferences of young adults with Type 1 diabetes at clinics using a discrete choice experiment approach: the D1 Now Study.
    Diabet Med. 2018 Sep 3. doi: 10.1111/dme.13809.
    PubMed     Text format     Abstract available

  13. GOPALAN A, Mishra P, Alexeeff SE, Blatchins MA, et al
    Prevalence and predictors of delayed clinical diagnosis of Type 2 diabetes: a longitudinal cohort study.
    Diabet Med. 2018 Sep 3. doi: 10.1111/dme.13808.
    PubMed     Text format     Abstract available

  14. HIRST JA, Farmer AJ, Smith MC, Stevens RJ, et al
    Timings for HbA1c testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data.
    Diabet Med. 2018 Sep 3. doi: 10.1111/dme.13810.
    PubMed     Text format     Abstract available

  15. SILVERMAN-RETANA O, Hulman A, Simmons RK, Nielsen J, et al
    Trajectories of obesity by spousal diabetes status in the English Longitudinal Study of Ageing.
    Diabet Med. 2018 Sep 3. doi: 10.1111/dme.13811.
    PubMed     Text format     Abstract available

  16. BOUGHTON CK, Hovorka R
    Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Diabet Med. 2018 Sep 5. doi: 10.1111/dme.13816.
    PubMed     Text format     Abstract available

  17. LEITER LA, Tinahones FJ, Karalis DG, Bujas-Bobanovic M, et al
    Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials.
    Diabet Med. 2018 Sep 5. doi: 10.1111/dme.13817.
    PubMed     Text format     Abstract available


    Diabetes

  18. BAKER RL, Jamison BL, Wiles TA, Lindsay RS, et al
    CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse.
    Diabetes. 2018;67:1836-1846.
    PubMed     Text format     Abstract available

  19. KHETAN S, Kursawe R, Youn A, Lawlor N, et al
    Type 2 Diabetes Associated Genetic Variants Regulate Chromatin Accessibility in Human Islets.
    Diabetes. 2018 Sep 4. pii: db18-0393. doi: 10.2337/db18-0393.
    PubMed     Text format     Abstract available

  20. STEHOUWER CDA
    Microvascular Dysfunction and Hyperglycemia: A Vicious Cycle With Widespread Consequences.
    Diabetes. 2018;67:1729-1741.
    PubMed     Text format     Abstract available

  21. DRUCKER DJ
    The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications.
    Diabetes. 2018;67:1710-1719.
    PubMed     Text format     Abstract available

  22. HASHIM M, Yokoi N, Takahashi H, Gheni G, et al
    Inhibition of SNAT5 Induces Incretin-Responsive State From Incretin-Unresponsive State in Pancreatic beta-Cells: Study of beta-Cell Spheroid Clusters as a Model.
    Diabetes. 2018;67:1795-1806.
    PubMed     Text format     Abstract available


    Diabetes Care

  23. DHINDSA S, Ghanim H, Batra M, Dandona P, et al
    Hypogonadotropic Hypogonadism in Men With Diabesity.
    Diabetes Care. 2018;41:1516-1525.
    PubMed     Text format     Abstract available

  24. LACY ME, Gilsanz P, Karter AJ, Quesenberry CP, et al
    Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes.
    Diabetes Care. 2018 Sep 4. pii: dc18-0073. doi: 10.2337/dc18-0073.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  25. YU M, Shankar RR, Zhang R, Zhang Y, et al
    Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with pre-mixed insulin.
    Diabetes Obes Metab. 2018 Sep 3. doi: 10.1111/dom.13517.
    PubMed     Text format     Abstract available

  26. SHIMIZU M, Suzuki K, Kato K, Jojima T, et al
    Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.
    Diabetes Obes Metab. 2018 Sep 3. doi: 10.1111/dom.13520.
    PubMed     Text format     Abstract available

  27. YOSHIKAWA F, Kumashiro N, Shigiyama F, Uchino H, et al
    Efficacy of Intermittent Empagliflozin Supplementation on Dietary Self-Management and Glycemic Control in Patients With Poorly Controlled Type 2 Diabetes: A 24-Week Randomized Controlled Trial.
    Diabetes Obes Metab. 2018 Sep 5. doi: 10.1111/dom.13524.
    PubMed     Text format     Abstract available

  28. SINGH RG, Nguyen NN, DeSouza SV, Pendharkar SA, et al
    Comprehensive analysis of body composition and insulin traits associated with intra-pancreatic fat deposition in health and new-onset prediabetes/diabetes after acute pancreatitis.
    Diabetes Obes Metab. 2018 Sep 5. doi: 10.1111/dom.13523.
    PubMed     Text format     Abstract available

  29. KHUNTI K, Seidu S, Davies MJ
    Should sodium glucose co-transporter 2 inhibitors be considered as first line oral therapy for people with type 2 diabetes?
    Diabetes Obes Metab. 2018 Sep 3. doi: 10.1111/dom.13518.
    PubMed     Text format     Abstract available

  30. NATALI A, Nesti L, Venturi E, Shore AC, et al
    Metformin is the key factor for elevated plasma GDF-15 levels in type 2 diabetes: a nested, case-control study.
    Diabetes Obes Metab. 2018 Sep 3. doi: 10.1111/dom.13519.
    PubMed     Text format     Abstract available

  31. KUO S, Yang CT, Wu JS, Ou HT, et al
    Effects of intensifying triple oral antidiabetic drug therapy by initiating insulin versus enhancing oral antidiabetic drug therapy on clinical outcomes in patients with type 2 diabetes: a nationwide population-based, propensity score-matched cohort s
    Diabetes Obes Metab. 2018 Sep 5. doi: 10.1111/dom.13525.
    PubMed     Text format     Abstract available


    Diabetologia

  32. VADIVELOO T, Jeffcoate W, Donnan PT, Colhoun HC, et al
    Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study.
    Diabetologia. 2018 Aug 31. pii: 10.1007/s00125-018-4723.
    PubMed     Text format     Abstract available

  33. HARDING JL, Pavkov ME, Magliano DJ, Shaw JE, et al
    Global trends in diabetes complications: a review of current evidence.
    Diabetologia. 2018 Aug 31. pii: 10.1007/s00125-018-4711.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  34. BERKOWITZ SA, Sussman JB, Jonas DE, Basu S, et al
    Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus.
    J Am Coll Cardiol. 2018;72:1214-1223.
    PubMed     Text format     Abstract available

  35. BAKRIS GL, Polonsky TS
    Presence of Diabetes Does Not Mandate Lower Blood Pressure to Reduce Cardiovascular Events.
    J Am Coll Cardiol. 2018;72:1224-1226.
    PubMed     Text format    


    J Am Soc Nephrol

  36. ERIGUCHI M, Bernstein EA, Veiras LC, Khan Z, et al
    The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.
    J Am Soc Nephrol. 2018 Sep 5. pii: ASN.2018030323. doi: 10.1681/ASN.2018030323.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  37. SOMMESE L, Benincasa G, Lanza M, Sorriento A, et al
    Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes.
    J Diabetes Complications. 2018 Aug 19. pii: S1056-8727(18)30633.
    PubMed     Text format     Abstract available

  38. ARNOLD SV, McGuire DK, Inzucchi SE, Tang F, et al
    Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).
    J Diabetes Complications. 2018 Aug 9. pii: S1056-8727(17)31407.
    PubMed     Text format     Abstract available


    J Pediatr

  39. MAHAJAN V, Goyal M
    Proximal Preaxial Hallucal Polysyndactyly with Tibial Hemimelia: Diabetic Embryopathy.
    J Pediatr. 2018 Aug 29. pii: S0022-3476(18)31097.
    PubMed     Text format    


    Kidney Int

  40. MICAKOVIC T, Papagiannarou S, Clark E, Kuzay Y, et al
    The angiotensin II type 2 receptors protect renal tubule mitochondria in early stages of diabetes mellitus.
    Kidney Int. 2018 Sep 3. pii: S0085-2538(18)30442.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol

  41. CHOW CK, Ramasundarahettige C, Hu W, AlHabib KF, et al
    Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
    Lancet Diabetes Endocrinol. 2018 Aug 28. pii: S2213-8587(18)30233.
    PubMed     Text format     Abstract available


  42. Correction to Lancet Diabetes Endocrinol 2018; published online July 30. https://doi.org/10.1016/S2213-8587(18)30074-3.
    Lancet Diabetes Endocrinol. 2018 Aug 30. pii: S2213-8587(18)30264.
    PubMed     Text format    


    Pediatr Diabetes

  43. TAMBORLANE WV, Chang P, Kollman C, Klingensmith GJ, et al
    Eligibility for clinical trials is limited for youth with type 2 diabetes (T2D): Insights from the Pediatric Diabetes Consortium T2D Clinic Registry.
    Pediatr Diabetes. 2018 Sep 2. doi: 10.1111/pedi.12763.
    PubMed     Text format     Abstract available

  44. PHELAN H, Lange K, Cengiz E, Gallego P, et al
    ISPAD Clinical Practice Consensus Guidelines 2018 Compendium Diabetes education in children and adolescents.
    Pediatr Diabetes. 2018 Sep 2. doi: 10.1111/pedi.12762.
    PubMed     Text format     Abstract available

  45. FINN BP, Power C, McSweeney N, Breen D, et al
    Subarachnoid and parencyhmal haemorrhages as a complication of severe diabetic ketoacidosis in a pre-adolescent with new onset type 1 diabetes.
    Pediatr Diabetes. 2018 Sep 2. doi: 10.1111/pedi.12760.
    PubMed     Text format     Abstract available

  46. PENA AS, Liew G, Anderson J, Giles LC, et al
    Early atherosclerosis is associated with retinal microvascular changes in adolescents with type 1 diabetes.
    Pediatr Diabetes. 2018 Sep 2. doi: 10.1111/pedi.12764.
    PubMed     Text format     Abstract available

  47. JOHNSON SR, Ellis JJ, Leo P, Anderson LK, et al
    Comprehensive genetic screening: the prevalence of MODY gene variants in a population-based childhood diabetes cohort.
    Pediatr Diabetes. 2018 Sep 7. doi: 10.1111/pedi.12766.
    PubMed     Text format     Abstract available

  48. CANDLER TP, Mahmoud O, Lynn RM, Majbar AA, et al
    Treatment adherence and BMI reduction are key predictors of HbA1c one year after diagnosis of childhood Type 2 Diabetes in UK.
    Pediatr Diabetes. 2018 Sep 2. doi: 10.1111/pedi.12761.
    PubMed     Text format     Abstract available


    PLoS One

  49. SIOOFY-KHOJINE AB, Oikarinen S, Honkanen H, Huhtala H, et al
    Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes.
    PLoS One. 2018;13:e0201959.
    PubMed     Text format     Abstract available

  50. SANCHES IC, Buzin M, Conti FF, Dias DDS, et al
    Combined aerobic and resistance exercise training attenuates cardiac dysfunctions in a model of diabetes and menopause.
    PLoS One. 2018;13:e0202731.
    PubMed     Text format     Abstract available

  51. FRAUNHOFFER NA, Meilerman Abuelafia A, Aquino Barrientos M, Cimerman KV, et al
    Long-term apoptosis-related protein expression in the diabetic mouse ovary.
    PLoS One. 2018;13:e0203268.
    PubMed     Text format     Abstract available

  52. MARTINEZ-LAGUNA D, Tebe C, Nogues X, Kassim Javaid M, et al
    Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort.
    PLoS One. 2018;13:e0203533.
    PubMed     Text format     Abstract available

  53. SOUTHARD SM, Kotipatruni RP, Rust WL
    Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents.
    PLoS One. 2018;13:e0203126.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: